Airain Ltd’s PDL BioPharma, Inc. PDLI Stock Holding History

Airain Ltd’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$141K	Buy	56,911 +9,893	+21%	+$22.8K	0.01%	779
2017 Q1	$107K	Buy	+47,018	New	+$104K	0.01%	754
2016 Q3	–	Sell	-87,024	Closed	-$273K	–	940
2016 Q2	$273K	Sell	87,024 -14,502	-14%	-$48.4K	0.02%	531
2016 Q1	$338K	Sell	101,526 -31,510	-24%	-$98.2K	0.02%	538
2015 Q4	$471K	Buy	133,036 +79,366	+148%	+$332K	0.03%	474
2015 Q3	$270K	Buy	+53,670	New	+$308K	0.02%	621
2015 Q2	–	Sell	-408,245	Closed	-$2.87M	–	1271
2015 Q1	$2.87M	Buy	408,245 +214,366	+111%	+$1.55M	0.18%	149
2014 Q4	$1.5M	Buy	193,879 +84,476	+77%	+$669K	0.12%	206
2014 Q3	$817K	Buy	+109,403	New	+$1.02M	0.06%	357
2014 Q2	–	Sell	-17,734	Closed	-$147K	–	1133
2014 Q1	$147K	Sell	17,734 -146,778	-89%	-$1.26M	0.03%	624
2013 Q4	$1.39M	Buy	+164,512	New	+$1.39M	0.18%	149
2013 Q3	–	Sell	-24,494	Closed	-$189K	–	804
2013 Q2	$189K	Buy	+24,494	New	+$191K	0.03%	479

Other funds holding PDLI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Airain Ltd's PDLI Position: Q2 2017 in Review

Airain Ltd increased its PDL BioPharma, Inc. (PDLI) stake by 21% in Q2 2017, buying an estimated $22.8K and bringing the position to 56,911 shares worth $141K. The position accounts for 0.01% of the portfolio, ranked #779.

Airain Ltd first reported a position in PDLI in Q2 2013 and has held it in 12 quarters since. The position peaked at $2.87M in Q1 2015. 171 funds tracked by Wall St. Rank hold PDLI as of Q2 2017.

Airain Ltd held 56,911 shares of PDL BioPharma, Inc. worth $141K as of Q2 2017.
Airain Ltd bought 9,893 PDL BioPharma, Inc. shares in Q2 2017, an estimated $22.8K.
PDL BioPharma, Inc. made up 0.01% of Airain Ltd's portfolio in Q2 2017, its #779 holding.
Airain Ltd first reported a position in PDL BioPharma, Inc. in Q2 2013 and has held it in 12 quarters since.
Airain Ltd's PDL BioPharma, Inc. position peaked at $2.87M in Q1 2015.
171 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q2 2017.

Based on Airain Ltd's 13F filing for Q2 2017, filed 8 Aug 2017.